C ardiac magnetic resonance (CMR) imaging generates exquisite tissue contrast to characterize the myocardium based on the proton density and magnetization properties. A wide range of CMR imaging sequences enables precise imaging of the function and morphology of the heart, using myocardialspecific T1 and T2 relaxation times. The ability of longitudinal relaxation time or T1 holds the potential to translate the tissuespecific property 1 into personalized predictive diagnostics. T1 measurement reflects the individual exponential time constant needed for 63% of the tissue magnetization to realign with the external magnetic field and become active again. Therefore, the shorter the T1, there are more protons available for imaging over the same period with brighter signal. Tissue edema, a wellknown cardinal sign of inflammation and tissue injury, lengthens the myocardial native T1 while shortens the postcontrast T1. Using novel CMR pulse sequences, it is possible to quantify the T1 value as it is encoded within each voxel.
C ardiac magnetic resonance (CMR) imaging generates exquisite tissue contrast to characterize the myocardium based on the proton density and magnetization properties. A wide range of CMR imaging sequences enables precise imaging of the function and morphology of the heart, using myocardialspecific T1 and T2 relaxation times. The ability of longitudinal relaxation time or T1 holds the potential to translate the tissuespecific property 1 into personalized predictive diagnostics. T1 measurement reflects the individual exponential time constant needed for 63% of the tissue magnetization to realign with the external magnetic field and become active again. Therefore, the shorter the T1, there are more protons available for imaging over the same period with brighter signal. Tissue edema, a wellknown cardinal sign of inflammation and tissue injury, lengthens the myocardial native T1 while shortens the postcontrast T1. 2 Using novel CMR pulse sequences, it is possible to quantify the T1 value as it is encoded within each voxel.
3 T1 values are then colored mapped to simplify visual interpretation. 4 T1 mapping has been used successfully to characterize normal myocardium, 5 nonischemic cardiomyopathy, 6 and acute and chronic myocardial infarction (MI). 7 In addition, the gadolinium-based contrast agents (GCAs), which are extracellular contrast agents capable of T1 shortening, further refine the diagnostic capability by measuring the postcontrast T1 to calculate the extracellular volume. 
See Article by Haberkorn et al
CMR late gadolinium enhancement (LGE) is the current gold standard for noninvasive quantification of the myocardial infarct size and fibrosis. 9 However, LGE requires an intravenous application of GCAs. Besides the contraindication in the setting of severe renal dysfunction, there is an ongoing U.S. Food and Drug Administration observation related to the accumulation of gadolinium in the vicinity of the brain stem in patients who have undergone multiple CMR examinations. 10 Furthermore, accurate diagnosis of less localized and diffuse myocardial pathologies, like nonischemic cardiomyopathy, still presents significant challenges. 2, 11 Infarct size and the resultant left ventricular (LV) remodeling and dysfunction are well-known clinical correlates. 12 The current revascularization approach in acute MI setting reduces the likelihood of future adverse ventricular remodeling and arrhythmia to enhance survival and decrease the incidence of heart failure. 13 Precise tissue characterization of the injured myocardium by T1 mapping will augment these efforts to allow accurate prognosis of myocardial injury and perhaps enable personalized medicine. Myocardial salvage may be assessed by delineating the myocardium at risk and the final infarct size using T1 map.
14 These novel efforts to assess the infarcted myocardium and ischemia/reperfusion injury will allow precise prediction of future cardiovascular events, which addresses a critical unmet need in heart failure.
Technical Advances in the Evaluation of Myocardial Injury
In this issue of the Journal Circulation: Cardiovascular Imaging, Haberkorn et al 15 report on the use of T1 mapping for accurate characterization of myocardial injury after complete permanent ligation of the left anterior descending coronary artery versus ischemia/reperfusion injury. This investigation studies the role of native and postcontrast T1 map and LGE to predict functional recovery after MI. Using 9.4-T scanner, CMR studies were obtained in 27 mice at 1 and 21 days after inducing MI. This study uses 2 welldefined experimental models of MI, uses endogenous CMR relaxometry, and demonstrates the potential to improve on GCAs to characterize the injured myocardium after MI. In particular, the native T1 maps derived from sequences with retrospective gating allowed an early and sensitive discrimination of the degree of tissue injury between the 2 models, enabling significant discrimination of differential functional outcome after LV remodeling. Comprehensive tissue characterization (LGE, pre/postcontrast T1, and T2) analyzed >200 sectors through the left ventricle demonstrates native T1 map to be the most predictive of functional recovery at 21 days post-MI. It is an important finding for 2 reasons. First, native T1 map does not require GCAs, which would eliminate the potential renal side effects, eliminate intravenous access, and reduce the cost of CMR. Elimination of LGE will also reduce variability in the study results and remove potential artifacts from the suboptimal inversion time and delayed image acquisition. Second, it provides important prognostic information at day 1 post-MI for personalized clinical decision-making regarding future therapies to prevent and treat arrhythmias and heart failure associated with post-MI LV dilatation and dysfunction.
Although the study's attempt to predict the amount of myocardial damage on day 1 post-MI is very intriguing and, Myocardial Edema Imaging After Infarction perhaps, necessary, there are several limitations or barriers to clinical translation. First, native T1 values of the remote healthy myocardium lacked reproducibility with large intersubject and intrasubject variabilities. T1 values ranged from 716.5±52.5 to 953.6±52.5 ms. In contrast, a study of 342 healthy volunteers using 1.5-T scanner showed reproducible and consistent T1 values within 2% of the average. 5 This inconsistency with T1 values is likely secondary to suboptimal image quality. Second, fractional shortening at day 21 was used as a surrogate of LV function and to draw correlations with native T1, T2, and LGE. It is well known that fractional shortening, especially in the presence of MI, is much inferior to other LV systolic function indexes, like LV ejection fraction or LV volumes as a surrogate. Third, this imaging acquisition hurdle is compounded by long postprocessing and quantitative analysis, which may prohibit robust clinical application. Fourth, clinical applicability could be limited by the heterogeneity of the myocardial injury on day 1 post-MI based on multiple uncontrollable issues: ischemia duration, disease severity, coronary anatomy, and comorbidities. Fifth, the LGE images, using intraperitoneal injection in this study, have less tissue contrast when compared with the intravenous injections. 16 Therefore, the superiority of native T1 mapping over postcontrast T1 and LGE needs to be reproduced in large animals and humans with intravenous GCAs use. Because T1 values increase with field strength, 15 we expect slightly different range of native T1 mapping at the 1.5-and 3-T clinical scanner from the high field 9.4 T.
Evaluation of T1 relaxation times of myocardial injury could be a very promising method to reveal the complex myocardial pathology post-MI and ischemia/reperfusion injury. 4 An integrated algorithm of optimized analysis of T1 map, preconditioning pattern, coronary anatomy, imaging protocol, culprit lesion, and thrombolysis in myocardial infarction flow grade may enable precise insight into the extent of myocardial injury and, more importantly, potential for salvage through better tissue characterization. A precise prognosis of post-MI patients may be possible by this predictive framework to delineate tissue heterogeneity of myocardial injury at day 1 post-MI. Acute changes, including edema, inflammation, periinfarct injury, and infarct core, may have adverse effects on cardiac remodeling and exacerbate myocardial cell stunning. The role of microvascular obstruction and its effect on T1 values could also be addressed. In final, the importance of heterogeneous tissue characteristics of the injured myocardium must be recognized. The heterogeneity of the injured cardiomyocytes in the peri-infarct region, characterized by uneven distribution of the GCAs and wider range of T1 value, has important prognostic significance with regards to cardiac dysfunction, arrhythmogenesis, and mortality. [17] [18] [19] Peri-infarct ischemia is a critical prognostic factor in postinfarct major adverse cardiac events. 19, 20 The role of ischemia/reperfusion injury and total occlusion in the formation of heterogeneous infarct tissues and eventual major adverse cardiac events needs to be elucidated.
Conclusions
In conclusion, the authors must be congratulated in overcoming the many challenges of imaging mice with average heart rate of >500 bpm at 9.4 T with 3×3 cm field of view to obtain an excellent in-plane spatial resolution of 0.12×0.12 mm in a scan time of 80 minutes. However, for the same exact reasons, the above-mentioned limitations may distance this technique from the translational efforts to achieve clinical application with reproducible findings. While promising, this method needs to be studied at a lower field with clinical scanners to determine whether this technique will allow a fast and comprehensive analysis of myocardial injury and provide meaningful patient-specific prognostic data for effective postinfarction therapy. The temporal and spatial changes of myocardial injury should be confirmed in clinical studies and correlated with cardiovascular events. These issues must be addressed to provide a more effective CMR technique to advance the predictive diagnosis of the patients who experience MI.
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